The role of monocyte chemotactic protein-3 (MCP3) in pyelonephritis patients in Al- Najaf governorate, Iraq

Автор: Al-janabi D.R.A., Aljanaby A.A.J.

Статья в выпуске: 31, 2024 года.

Бесплатный доступ

Pyelonephritis is a serious disease that is widespread in Iraq and is mostly caused by Gram-negative bacteria, which are highly contagious and can spread from an infected person to others. The aim of this article was to evaluate the immunomodulatory role of Monocyte chemotactic protein-3 (MCP3) in the blood serum of patients with acute pyelonephritis and chronic pyelonephritis. A group of patients suspected of having nephritis were sampled in Najaf city, Iraq. Clinical and biochemical tests were performed to confirm their infection. Where 30 patients had acute pyelonephritis and 30 patients had chronic pyelonephritis, in addition to 29 healthy people who were considered control. MPC-3 was measured in the serum of the affected person using ELISA technology. MPC3 levels were significantly elevated (P

Еще

Monocyte chemotactic protein-3 (mcp3), acute pyelonephritis, chronic pyelonephritis

Короткий адрес: https://sciup.org/148328837

IDR: 148328837 | DOI: 10.18137/cardiometry.2024.31.105109

Список литературы The role of monocyte chemotactic protein-3 (MCP3) in pyelonephritis patients in Al- Najaf governorate, Iraq

B. M. Muhammad-Baqir, A. A. Fattah, D. R. A. Al-janabi, and A. A. J. Aljanaby, “The prevalence study of patients infected with pyelonephritis by in Al Najaf Governorate, Iraq,” in BIO Web of Conferences, EDP Sciences, 2023, p. 5049.
S. Siriwardana and C. Piyabani, “Role of Imaging in Renal Infections: A Narrative Review,” 2023.
J. J. Djuraevich, “Gestational Pyelonephritis in Pregnancy,” Am. J. Pediatr. Med. Heal. Sci., vol. 2, no. 1, pp. 348–352, 2024.
S. Woo et al., “Clinical factors distinguishing renal infarction from acute pyelonephritis: A randomly matched retrospective case-control study,” Am. J. Emerg. Med., vol. 72, pp. 88–94, 2023.
R. Yamashita, Y. Izumi, K. Nakada, and J. Hiramoto, “Utility of urinary presepsin in the diagnosis of pyelonephritis: a cross-sectional study,” BMC Infect. Dis., vol. 23, no. 1, p. 365, 2023.
D. R. A. Al-janabi and A. A. J. Aljanaby, “Bacteriological investigation of pyelonephritis in AL-Najaf Governorate, Iraq: a cross-Sectional study,” in BIO Web of Conferences, EDP Sciences, 2024, p. 3014.
H. Trujillo-Santamaría et al., “A novel mortality risk score for emphysematous pyelonephritis: A multicenter study of the Global Research in the Emphysematous Pyelonephritis group,” Curr. Urol., vol. 18, no. 1, pp. 55–60, 2024.
K. Gulati, S. Guhathakurta, J. Joshi, N. Rai, and A. Ray, “Cytokines and their role in health and disease: a brief overview,” Moj Immunol, vol. 4, no. 2, p. 121, 2016.
J. J. O’Shea, M. Gadina, and R. M. Siegel, “Cytokines and cytokine receptors,” in Clinical immunology, Elsevier, 2019, pp. 127–155.
S. She, L. Ren, P. Chen, D. Chen, and Y. Wang, “Functional roles of chemokine receptor CCR2 and its ligands in liver disease,” Front. Immunol., vol. 13, p. 812431, 2022.
S. Zhu, M. Liu, S. Bennett, Z. Wang, K. D. G. Pfleger, and J. Xu, “The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseases,” J. Cell. Physiol., vol. 236, no. 10, pp. 7211–7222, 2021.
Y. Liu, Y. Cai, L. Liu, Y. Wu, and X. Xiong, “Crucial biological functions of CCL7 in cancer,” PeerJ, vol. 6, p. e4928, 2018.
D. R. A. Al-Janabi, A. A. Fattah, A. A. J. Aljanaby, and W. H. Alhissnawy, “Comparison of Some Blood Parameters and Vitamin D3 for Patients with Pyelonephritis and Renal Failure in Najaf Governorate, Iraq,” Ren. Fail., vol. 91, no. 50.93, p. 10.
D. R. A. Al-janabi, Y. A. Shallani, L. A. D. Albakaa, and A. A. J. Aljanaby, “Prevalence of types of cancer in Najaf Governorate and comparison of leukemia with other types,” J. Biomed. Biosens., vol. 4, no. 2, pp. 1–10, 2024.
H. M. H. Al-aaraji, M. R. Mansor, and D. R. A. Al-janabi, “The role of IL-6, IL-8 and TNF-α in COVID-19 patients in Karbala Governorate,” in E3S Web of Conferences, EDP Sciences, 2023.
S. Singh, D. Anshita, and V. Ravichandiran, “MCP- 1: Function, regulation, and involvement in disease,” Int. Immunopharmacol., vol. 101, p. 107598, 2021.
S. M. Y. Mhana and A. A. J. Aljanaby, “Bacteriological and Immunological study of kidney failure patients infected with urinary tract infections,” in E3S Web of Conferences, EDP Sciences, 2023, p. 3110.
H. Strang et al., “Role of cytokines and chemokines in wound healing,” in Wound healing, tissue repair, and regeneration in diabetes, Elsevier, 2020, pp. 197–235.
Y. Bao and X. Zhu, “Role of chemokines and inflammatory cells in respiratory allergy,” J. Asthma Allergy, pp. 1805–1822, 2022.
R. Yudhawati and K. Shimizu, “PGE2 produced by exogenous MSCs promotes immunoregulation in ARDS induced by highly pathogenic influenza a through activation of the wnt-β-catenin signaling pathway,” Int. J. Mol. Sci., vol. 24, no. 8, p. 7299, 2023.
T. C. Dos Santos et al., “Approaches of marine compounds and relevant immune mediators in Autism Spectrum Disorder: Opportunities and challenges,” Eur. J. Med. Chem., p. 116153, 2024.
M. Boshtam, S. Asgary, S. Kouhpayeh, L. Shariati, and H. Khanahmad, “Aptamers against pro-and anti-inflammatory cytokines: a review,” Inflammation, vol. 40, pp. 340–349, 2017.
A. Mantovani, S. Sozzani, P. Proost, and J. Van Damme, “The monocyte chemoattractant protein family,” in Chemoattractant ligands and their receptors, CRC Press, 2020, pp. 169–192.
L. Wang, J. Lan, J. Tang, and N. Luo, “MCP-1 targeting: Shutting off an engine for tumor development,” Oncol. Lett., vol. 23, no. 1, pp. 1–9, 2022.
A. Gowhari Shabgah, F. Jadidi-Niaragh, H. Mohammadi, and J. Gholizadeh Navashenaq, “The role of atypical chemokine receptor D6 (ACKR2) in physiological and pathological conditions; friend, foe, or both?,” Front. Immunol., vol. 13, p. 861931, 2022.

Еще

Статья научная